Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
The modest protective effects of the RV144 HIV-1 vaccine trial have prompted the further exploration of improved poxvirus vector systems that can yield better immune responses and protection. In this study, a recombinant lumpy skin disease virus (LSDV) expressing HIV-1 CAP256.SU gp150 (Env) and a su...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI AG
2021-11-01
|
| Colección: | Vaccines |
| Materias: | |
| Acceso en línea: | https://www.mdpi.com/2076-393X/9/11/1281 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|